GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CKD Bio Corp (XKRX:063160) » Definitions » Ending Cash Position

CKD Bio (XKRX:063160) Ending Cash Position : ₩-3,647 Mil (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is CKD Bio Ending Cash Position?

CKD Bio's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩-3,647 Mil.

CKD Bio's quarterly Ending Cash Position increased from Jun. 2023 (₩1,070 Mil) to Sep. 2023 (₩7,277 Mil) but then declined from Sep. 2023 (₩7,277 Mil) to Dec. 2023 (₩-3,647 Mil).

CKD Bio's annual Ending Cash Position increased from Dec. 2021 (₩3,466 Mil) to Dec. 2022 (₩4,655 Mil) but then declined from Dec. 2022 (₩4,655 Mil) to Dec. 2023 (₩3,630 Mil).


CKD Bio Ending Cash Position Historical Data

The historical data trend for CKD Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CKD Bio Ending Cash Position Chart

CKD Bio Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,492.64 1,463.27 3,465.83 4,655.29 3,630.22

CKD Bio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,655.29 3,103.49 1,069.96 7,277.45 -3,647.23

CKD Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CKD Bio's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4655.287+-1025.065
=3,630

CKD Bio's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.0010000000006585+-3647.226
=-3,647


CKD Bio Ending Cash Position Related Terms

Thank you for viewing the detailed overview of CKD Bio's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


CKD Bio (XKRX:063160) Business Description

Traded in Other Exchanges
N/A
Address
368 Chungjeongno 3-ga, Seodaemun-gu, Seoul, KOR, 120-756
CKD Bio Corp is engaged in manufacturing and distribution of pharmaceutical materials and medicines. Its products portfolio include antibiotic, lactamase inhibitors, antituberculosis, antidiabetics, immunosuppressants, antihyperlipidemics, intermediates, and probiotics.

CKD Bio (XKRX:063160) Headlines

No Headlines